Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Clinical trial NCT07145229 · RECRUITING

Trial details

NCT number: NCT07145229
Sponsor: Atom Therapeutics Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Gouty Arthritis Gout Flare Gout Flares Acute Gout Flare

Start date: 2025-08-26
Primary completion: 2026-05-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.